The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991 - PubMed (original) (raw)
. 2000 May;27(5):1247-50.
Affiliations
- PMID: 10813295
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991
M Shbeeb et al. J Rheumatol. 2000 May.
Abstract
Objective: To determine the incidence, prevalence, and outcomes of psoriatic arthritis (PsA) in a geographically defined community.
Methods: Using the Rochester Epidemiology Project computerized medical record system, we screened all records of Olmsted County, Minnesota, residents with any diagnosis consistent with psoriasis and/or PsA made between January 1, 1982 and December 31, 1991. Medical records were reviewed using a pretested data collection form. Only those cases of psoriasis where the diagnosis was confirmed by a dermatologist were included. PsA was defined as inflammatory arthritis associated with a definite diagnosis of psoriasis. All identified cases were followed until death, migration from the county, or January 1, 1992. Cases with seropositive rheumatoid arthritis, systemic lupus erythematosus, crystal induced arthritis, Reiter's syndrome, arthritis associated with inflammatory bowel diseases, and inflammatory osteoarthritis were excluded. Clinical characteristics were described using summary statistics. Age and sex adjusted incidence and prevalence rates were calculated. Survival was estimated using the Kaplan-Meier method.
Results: We reviewed the records of 1844 patients with a diagnosis of psoriasis. In 1056 of these, the diagnosis was confirmed by a dermatologist. Among these 1056 psoriasis cases, we identified 66 cases (34 female, 32 male) of PsA first diagnosed between 1982 and 1991. The average age and sex adjusted incidence rate per 100,000 US population was 6.59 (95% confidence interval, CI, 4.99, 8.19) and the prevalence on January 1, 1992, was about one per 1000 (95% CI 0.81, 1.21). The average age at diagnosis was 40.7 years. At diagnosis, 91, 3, and 6% of cases had oligoarthritis, polyarthritis, and spondylitis, respectively. Over the 477.8 person-years of followup, 25 developed extraarticular manifestations (enthesitis, n = 15; ocular inflammation, n = 11; urethritis, n = 9), 10 patients received disease modifying antirheumatic drug treatment (methotrexate, n = 7; sulfasalazine, n = 5; intramuscular gold, n = 1; oral gold, n = 1), 3 received corticosteroids, and 5 had surgical interventions (synovectomy, n = 3; arthroplasty, n = 1; other reconstructive surgery, n = 2). Survival was not significantly different from the general population (p = 0.546).
Conclusion: Unlike results from previous referral based studies, our findings indicate that PsA is a mild, uncommon inflammatory arthritis, not associated with a significant increase in mortality.
Comment in
- The epidemiology of psoriatic arthritis: fact or fiction?
Veale DJ. Veale DJ. J Rheumatol. 2000 May;27(5):1105-6. J Rheumatol. 2000. PMID: 10813271 No abstract available. - The epidemiology of psoriatic arthritis.
Gabriel SE. Gabriel SE. J Rheumatol. 2001 Mar;28(3):678. J Rheumatol. 2001. PMID: 11296984 No abstract available.
Similar articles
- Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway.
Nossent JC, Gran JT. Nossent JC, et al. Scand J Rheumatol. 2009;38(4):251-5. doi: 10.1080/03009740802609558. Scand J Rheumatol. 2009. PMID: 19247847 - Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
Madland TM, Apalset EM, Johannessen AE, Rossebö B, Brun JG. Madland TM, et al. J Rheumatol. 2005 Oct;32(10):1918-22. J Rheumatol. 2005. PMID: 16206347 - Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ, Chang YT, Shen JL, Chen TT, Wang CB, Chen CM, Wu CY. Chen YJ, et al. Arthritis Rheum. 2012 Jun;64(6):1879-87. doi: 10.1002/art.34335. Epub 2011 Dec 12. Arthritis Rheum. 2012. PMID: 22161801 - Psoriatic arthritis: recent progress in pathophysiology and drug development.
Veale DJ. Veale DJ. Arthritis Res Ther. 2013;15(6):224. doi: 10.1186/ar4414. Arthritis Res Ther. 2013. PMID: 24611179 Free PMC article. Review. - [[WHAT SHOULD BE KNOWN ABOUT PSORIATIC ARTHRITIS]?].
Kehler T, Čabrijan L. Kehler T, et al. Acta Med Croatica. 2015;69(2):111-5. Acta Med Croatica. 2015. PMID: 29076711 Review. Croatian.
Cited by
- Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.
Ogdie A, Haynes K, Troxel AB, Love TJ, Hennessy S, Choi H, Gelfand JM. Ogdie A, et al. Ann Rheum Dis. 2014 Jan;73(1):149-53. doi: 10.1136/annrheumdis-2012-202424. Epub 2012 Dec 21. Ann Rheum Dis. 2014. PMID: 23264338 Free PMC article. - [Psoriatic arthritis].
Cauza E, Dunky A. Cauza E, et al. Wien Med Wochenschr. 2006 Nov;156(21-22):587-95. doi: 10.1007/s10354-006-0276-7. Wien Med Wochenschr. 2006. PMID: 17160376 Review. German. - The Risk of Mortality among Psoriatic Patients with Varying Severity: A Nationwide Population-Based Cohort Study in Taiwan.
Dai YX, Hsu MC, Hu HY, Chang YT, Chen TJ, Li CP, Wu CY. Dai YX, et al. Int J Environ Res Public Health. 2018 Nov 22;15(12):2622. doi: 10.3390/ijerph15122622. Int J Environ Res Public Health. 2018. PMID: 30467301 Free PMC article. - The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project.
Andersen LK, Davis MD. Andersen LK, et al. Mayo Clin Proc. 2013 Dec;88(12):1462-7. doi: 10.1016/j.mayocp.2013.08.018. Mayo Clin Proc. 2013. PMID: 24290120 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous